Search bioRxivSearch

bioRxiv · 10.1101/2020.01.11.900977

Electrophysiological Frequency Band Ratio Measures Conflate Periodic and Aperiodic Neural Activity

Abstract

A common analysis measure for neuro-electrophysiological recordings is to compute the power ratio between two frequency bands. Applications of band ratio measures include investigations of cognitive processes as well as biomarkers for conditions such as attention-deficit hyperactivity disorder. Band ratio measures are typically interpreted as reflecting quantitative measures of periodic, or oscillatory, activity, which implicitly assumes that a ratio is measuring the relative powers of two distinct periodic components that are well captured by predefined frequency ranges. However, electrophysiological signals contain periodic components and a 1/f-like aperiodic component, which contributes power across all frequencies. In this work, we investigate whether band ratio measures reflect power differences between two oscillations, as intended. We examine to what extent ratios may instead reflect other periodic changes--such as in center frequency or bandwidth--and/or aperiodic activity. We test this first in simulation, exploring how band ratio measures relate to changes in multiple spectral features. In simulation, we show how multiple periodic and aperiodic features affect band ratio measures. We then validate these findings in a large electroencephalography (EEG) dataset, comparing band ratio measures to parameterizations of power spectral features. In EEG, we find that multiple disparate features influence ratio measures. For example, the commonly applied theta / beta ratio is most reflective of differences in aperiodic activity, and not oscillatory theta or beta power. Collectively, we show how periodic and aperiodic features can drive the same observed changes in band ratio measures. Our results demonstrate how ratio measures reflect different features in different contexts, inconsistent with their typical interpretations. We conclude that band ratio measures are non-specific, conflating multiple possible underlying spectral changes. Explicit parameterization of neural power spectra is better able to provide measurement specificity, elucidating which components of the data change in what ways, allowing for more appropriate physiological interpretations. Materials Descriptions & Availability StatementsO_ST_ABSProject RepositoryC_ST_ABSThis project is also made openly available through an online project repository in which the code and data are made available, with step-by-step guides through the analyses. Project Repository: http://github.com/voytekresearch/BandRatios DatasetsThis project uses simulated data, literature text mining data, and electroencephalography data. Simulated DataThe simulations used in this project are created with openly available software packages. Settings and code to re-generate simulated data is available with the open-access code for the project. Copies of the simulated data that were used in this investigation are available in the project repository. Literature DataLiterature data for this project was collected from the PubMed database. Exact search terms used to collect the data are available in the project repository. The exact data collected from the literature and meta-data about the collection are saved and available in the project repository. EEG DataThe EEG data used in this project is from the openly available dataset, the Multimodal Resource for Studying Information processing in the Developing Brain (MIPDB) database. This dataset is created and released by the Childmind Institute. This dataset was released and is re-used here under the terms of the Creative Commons-Attribution-Non-Commercial-Share-Alike License (CC-BY-NC-SA), and is described in (Langer et al., 2017). Child Mind Institute: https://childmind.org Data Portal: http://fcon_1000.projects.nitrc.org/indi/cmi_eeg/ SoftwareCode used and written for this project was written in the Python programming language. All the code used within this project is deposited in the project repository and is made openly available and licensed for re-use. As well as standard library Python, this project uses 3rd party software packages numpy and pandas for data management, scipy for data processing, matplotlib and seaborn for data visualization and MNE for managing and pre-processing data. This project also uses open-source Python packages developed and released by the authors: Simulations and spectral parameterization were done using the FOOOF toolbox. Code Repository: https://github.com/fooof-tools/fooof Literature collection and analyses were done using the LISC toolbox. Code Repository: https://github.com/lisc-tools/lisc

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Donoghue, T., Dominguez, J., Voytek, B.. 2020-01-11. Electrophysiological Frequency Band Ratio Measures Conflate Periodic and Aperiodic Neural Activity. https://doi.org/10.1101/2020.01.11.900977

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience